We evaluated the relationship between admission white blood cell (WBC) count and in-hospital outcomes in acute coronary syndrome (ACS) patients from the Middle East. Data were analyzed from 7806 consecutive patients with ACS who were divided into 4 groups (G) according to their WBC count (×109/L; G1: <6.00; G2: 6.00-9.99; G3: 10.00-11.99; G4: ≥12.00). After significant covariate adjustment, those in G4 were 68% more likely to have cardiogenic shock than those in G1 (95% confidence interval [CI]: 1.05-2.68; P = .030) and G2 (odds ratio [OR], 2.02; 95% CI: 1.51-2.71; P < .001). Those in G4 were 2.02 times (95% CI: 1.11-3.67; P = .021) and 65% (95% CI: 1.17-2.32; P = .004) more likely to die in hospital than those in G1 and G2, respectively. Admission WBC count is an independent risk factor for in-hospital cardiogenic shock and mortality, in Middle Eastern patients with ACS. Novel therapeutic agents targeting WBCs in patients with ACS may improve outcomes.
MadjidMAwanIWillersonJTCasscellsSW. Leukocyte count and coronary heart disease: implications for risk assessment. J Am Coll Cardiol. 2004;44(10):1945–1956.
3.
TurnerSJKetchTRGandhiSKSaneDC. Routine hematologic clinical tests as prognostic markers in patients with acute coronary syndromes. Am Heart J. 2008;155(5):806–816.
4.
BogatyPBoyerLSimardS. Clinical utility of C-reactive protein measured at admission, hospital discharge, and 1 month later to predict outcomes in patients with acute coronary disease. The RISCA (recurrence and inflammation in the acute coronary syndromes) study. J Am Coll Cardiol. 2008;51(24):2339–2346.
5.
BarronHVCannonCPMurphySABraunwaldEGibsonCM. Association between white blood cell count, epicardial blood flow, myocardial perfusion, and clinical outcomes in the setting of acute myocardial infarction: a thrombolysis in myocardial infarction 10 substudy. Circulation. 2000;102(19):2329–2334.
6.
CannonCPMcCabeCHWilcoxRGBentleyJHBraunwaldE. Association of white blood cell count with increased mortality in acute myocardial infarction and unstable angina pectoris. OPUSTIMI 16 Investigators. Am J Cardiol. 2001;87(5):636–639.
7.
BarronHVHarrSDRadfordMJWangYKrumholzHM. The association between white blood cell count and acute myocardial infarction mortality in patients > or =65 years of age: findings from the cooperative cardiovascular project. J Am Coll Cardiol. 2001;38(6):1654–1661.
8.
SabatineMSMorrowDACannonCP. Relationship between baseline white blood cell count and degree of coronary artery disease and mortality in patients with acute coronary syndromes: a TACTICS-TIMI 18 (Treat Angina with Aggrastat and determine Cost of Therapy with an Invasive or Conservative Strategy-Thrombolysis in Myocardial Infarction 18 trial) substudy. J Am Coll Cardiol. 2002;40(10):1761–1768.
9.
MuellerCNeumannFJPerruchoudAPBuettnerHJ. White blood cell count and long term mortality after non-ST elevation acute coronary syndrome treated with very early revascularisation. Heart. 2003;89(4):389–392.
10.
GrzybowskiMWelchRDParsonsL. The association between white blood cell count and acute myocardial infarction in-hospital mortality: findings from the National Registry of Myocardial Infarction. Acad Emerg Med. 2004;11(10):1049–1060.
11.
MenonVLessardDYarzebskiJFurmanMIGoreJMGoldbergRJ. Leukocytosis and adverse hospital outcomes after acute myocardial infarction. Am J Cardiol. 2003;92(4):368–372.
12.
FurmanMIGoreJMAndersonFA. Elevated leukocyte count and adverse hospital events in patients with acute coronary syndromes: findings from the Global Registry of Acute Coronary Events (GRACE). Am Heart J. 2004;147(1):42–48.
13.
IshiharaMKojimaSSakamotoT. Usefulness of combined white blood cell count and plasma glucose for predicting in-hospital outcomes after acute myocardial infarction. Am J Cardiol. 2006;97(11):1558–1563.
14.
O’DonoghueMMorrowDACannonCP. Association between baseline neutrophil count, clopidogrel therapy, and clinical and angiographic outcomes in patients with ST-elevation myocardial infarction receiving fibrinolytic therapy. Eur Heart J. 2008;29(8):984–991.
15.
ZubaidMRashedWAAl-KhajaN. Clinical presentation and outcomes of acute coronary syndromes in the Gulf Registry of Acute Coronary Events (Gulf RACE). Saudi Med J. 2008;29(2):251–255.
16.
CannonCPBattlerABrindisRG. American College of Cardiology key data elements and definitions for measuring the clinical management and outcomes of patients with acute coronary syndromes. A report of the American College of Cardiology Task Force on Clinical Data Standards (Acute Coronary Syndromes Writing Committee). J Am Coll Cardiol. 2001;38(7):2114–2130.
17.
LemeshowSHosmerDWJ. A review of goodness of fit statistics for use in the development of logistic regression models. Am J Epidemiol. 1982;115(1):92–106.
18.
HanleyJAMcNeilBJ. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology. 1982;143(1):29–36.
19.
GrangerCBGoldbergRJDabbousO. Global Registry of Acute Coronary Events Investigators. Predictors of hospital mortality in the global registry of acute coronary events. Arch Intern Med. 2003;163(19):2345–2353.
20.
RaffelOCTearneyGJGauthierDDHalpernEFBoumaBEJangIK. Relationship between a systemic inflammatory marker, plaque inflammation, and plaque characteristics determined by intravascular optical coherence tomography. Arterioscler Thromb Vasc Biol. 2007;27(8):1820–1827.
21.
UesugiTIwasakiKMurakamiM. Circulating white blood cell count correlates with left ventricular indices independently of the extent of risk area for myocardial infarction after successful reperfusion. Acta Cardiol. 2004;59(5):533–539.
22.
Vinten-JohansenJ. Involvement of neutrophils in the pathogenesis of lethal myocardial reperfusion injury. Cardiovasc Res. 2004;61(3):481–497.
LaviSPrasadAYangEH. Smoking is associated with epicardial coronary endothelial dysfunction and elevated white blood cell count in patients with chest pain and early coronary artery disease. Circulation. 2007;115(20):2621–2617.
25.
AsadollahiKBeechingNJGillGV. Leukocytosis as a predictor for non-infective mortality and morbidity. QJM. 2010;103(5):285–292.
26.
SanchezPLMorinigoJLPabonP. Prognostic relations between inflammatory markers and mortality in diabetic patients with non-ST elevation acute coronary syndrome. Heart. 2004;90(3):264–269.
27.
Arruda-OlsonAMReederGSBellMRWestonSARogerVL. Neutrophilia predicts death and heart failure after myocardial infarction: a community-based study. Circ Cardiovasc Qual Outcomes. 2009;2(6):656–662.
28.
KrukMKarczMPrzyłuskiJ. White blood cell count adds prognostic information to the thrombolysis in myocardial infarction risk index in patients following primary percutaneous coronary intervention (ANIN Myocardial Infarction Registry). Int J Cardiol. 2007;116(3):376–382.
29.
IkedaYYoungLHLeferAM. Attenuation of neutrophil-mediated myocardial ischemia-reperfusion injury by a calpain inhibitor. Am J Physiol Heart Circ Physiol. 2002;282(4):H1421–1426.
30.
CollerBS. Leukocytosis and ischemic vascular disease morbidity and mortality: is it time to intervene?. Arterioscler Thromb Vasc Biol. 2005;25(4):658–670.
31.
AzabBZaherMWeiserbsKF. Usefulness of neutrophil to lymphocyte ratio in predicting short- and long-term mortality after non-ST-elevation myocardial infarction. Am J Cardiol. 2010;106(4):470–476.
